direct answers, with gaps left clear
CJC-1295 FAQ: the drug is not approved for people.
This page answers questions about harm, testosterone, sport, and the two forms. The few human tests were short.
No long human test has settled safety
This lab-made peptide remains unapproved for people. These answers cover possible harm and the risks that no long human test has settled.
Do we know whether CJC-1295 is safe for long use?
No long human study can answer that question. CJC-1295 has no approved use in people.
Growth hormone can make the kidneys hold salt and water, which may cause swelling. Insulin-like growth factor 1, a liver-made hormone, may matter for some cancers [7].
The FDA also warned that the immune system might learn to fight the drug as foreign [9]. That could cause a reaction or keep the drug from working as planned.
What remains unknown about CJC-1295 safety?
The human work only used short tests of how the drug moved through blood [1]. It did not show what happens after long use.
Growth hormone can make your body hold water. Higher insulin-like growth factor 1 has been tied to some cancers [7].
That cancer link does not prove CJC-1295 causes cancer. The FDA also warned that the immune system might fight the drug [9].
Which CJC-1295 side effects have a medical reason behind them?
Swelling and blood-sugar trouble have a sound medical reason behind them. Growth hormone can make the kidneys keep salt and water, and it can make insulin lower sugar less well.
A long rise in insulin-like growth factor 1 also raises a cancer question [7]. Research on insulin-like growth factor 1 does not prove CJC-1295 causes cancer.
The FDA noted a chance that the immune system could fight the drug as foreign [9]. No long human test tells us how often any of these problems happen.
What CJC-1295 side effects do users describe?
People using the drug describe swelling, tingling, headaches, and higher blood sugar. These are personal accounts, not results from a controlled study.
Growth hormone can make the kidneys hold water. Higher insulin-like growth factor 1 has been tied to some cancers in large groups [7].
Research on insulin-like growth factor 1 does not prove the drug causes cancer. The FDA also raised concern that the immune system might fight it [9].
The drug is a peptide, not a steroid or approved drug
Is CJC-1295 a muscle-building steroid?
No. The drug is a peptide, a short chain made from protein parts, and it tells the growth gland under your brain to release your own growth hormone [2]. A muscle-building steroid works through male sex hormones, so it acts in a different way.
Has the FDA approved CJC-1295 for people?
No. CJC-1295 has no FDA approval for human use [1].
In 2024, an FDA group separately asked whether pharmacies should be allowed to mix it from raw drug powder. That review was not an approval review.
The group did not back pharmacy mixing. One reason was concern that the immune system might fight the drug as foreign [9].
The tests did not settle testosterone effects
Did CJC-1295 raise or lower testosterone in human tests?
CJC-1295 works through growth hormone and insulin-like growth factor 1, a hormone made in the liver, while testosterone belongs to the male sex-hormone system and works in a different way. The tests measured insulin-like growth factor 1, not testosterone [3], so they couldn't settle whether testosterone rose or fell.
Is there proof that CJC-1295 lowers testosterone?
No controlled human test found that CJC-1295 lowers testosterone, because the trials followed growth hormone and insulin-like growth factor 1 instead and did not focus on the male sex hormone [3]. They can't rule a testosterone rise or fall in or out.
Are research peptides safer than testosterone treatment?
The two can't be fairly ranked. Testosterone treatment has approved uses, doctor checks, and a long record.
CJC-1295 is an unapproved research drug with only short human tests [1]. Tesamorelin is a related approved drug tested in people with HIV and belly fat [6].
Results for tesamorelin do not prove the research peptide is safe. Each drug needs its own sound human tests.
Sport bans the drug, and its two forms last different times
The drug also raises questions about sport rules and its two forms. These answers explain the ban, the human tests, and the name mix-up.
Do sport rules ban CJC-1295?
Sport rules ban CJC-1295 under Section S2, the part of the rule book covering peptide hormones, and the NCAA bans it during and between contests as well. A sports lab found the drug in a seized product [8], so a tested athlete could lose the right to compete.
What did the human CJC-1295 tests measure?
Early human tests briefly tracked growth hormone and insulin-like growth factor 1 [1][3]. They did not prove better health or long-term safety.
ConjuChem, the company running a Phase 2 program, included people with HIV and deep belly fat. The program stopped after a reported death, though public records do not show that the drug caused the death [1].
No large, long safety test in healthy adults was finished. That missing work is why the safety answer remains open.
Why are CJC-1295 and the short form, Modified GRF 1-29, confused?
Both forms begin with the same short copy of a body hormone, but only the long form has a hook that holds albumin, a common protein, in your blood much longer. That hook is the key difference.
The hook makes the long form last for days [1]. The short form lacks the hook and lasts minutes or hours.